DOI: 10.1055/s-00000071

Seminars in Neurology


Pareyson D, Schenone A, Fabrizi GM , et al; CMT-TRIAAL Group.
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol [EudraCT no.: 2006-000032-27].
[EudraCT no.: 2006–000032–27]
Pharmacol Res 2006;
54 (6) 436-441

Download Bibliographical Data

Search in: